If you have ever been handed an AMH result and told it was low, you probably walked out of that appointment carrying something you did not expect to be carrying.
A quiet worry. A sense that your window was narrowing. Maybe a referral, or a rushed conversation, or simply the feeling that a single number had just rewritten your story before it even began.
Here is what we want you to know today.
That number is not your story.
A landmark study published in JAMA followed women aged 30 to 44 who were actively trying to conceive naturally. Women with low AMH were just as likely to get pregnant as women with normal AMH.
Read that again.
Your AMH tells a meaningful story. But it is not the story most people think it is. And understanding the difference could change everything about how you move forward — with clarity, with information, and with a plan that is actually built around you.
What AMH Actually Measures
AMH, or Anti-Müllerian hormone, is produced by the granulosa cells of your small developing follicles. It reflects the size of your remaining follicle pool — how many eggs are waiting in reserve. Think of it as a gauge, not a verdict. A starting point, not a destination.
A generally adequate reserve is indicated by an AMH above 1 ng/mL. Very high levels above approximately 6 ng/mL can suggest PCOS. Very low levels suggest diminished ovarian reserve.
Where AMH is genuinely useful: predicting how your ovaries will respond to stimulation medications during IVF. It helps clinicians personalize protocols and anticipate your body's response. In that context it is a valuable clinical tool.
Where AMH is routinely misused: as a standalone predictor of your ability to conceive naturally. And that distinction matters enormously, because those two things are not the same.
The JAMA study was unambiguous. Low AMH did not translate to lower pregnancy rates in women trying to conceive without medical intervention. Natural fertility is governed by far more than ovarian reserve alone. Oocyte quality, tubal function, uterine receptivity, sperm health, and cycle timing all play significant roles that a single AMH number says nothing about.
The American College of Obstetricians and Gynecologists has explicitly cautioned against using AMH for fertility counseling in women without an infertility diagnosis for exactly this reason. A single number, without full context, is not a prognosis. It is an invitation to look deeper.
What AMH Does Not Tell You
AMH says nothing about egg quality. This is one of the most important and most frequently overlooked distinctions in fertility medicine. You can have a robust reserve of follicles and still face challenges if egg quality is affected by oxidative stress, mitochondrial dysfunction, nutrient deficiencies, or metabolic imbalance. And the reverse is equally true: a smaller reserve does not mean the eggs that remain are of poor quality. The eggs you have may be exceptional.
AMH also does not account for several factors that can falsely suppress the number without reflecting your true reserve. Hormonal contraceptive use suppresses AMH measurably. Higher BMI is associated with lower AMH independent of actual ovarian reserve. If your number was drawn while you were on the pill, the result you received may not reflect your actual baseline at all.
That is not a small caveat. That is genuinely good news.
What Can Actually Move the Needle
This is where the functional approach becomes genuinely exciting. While no intervention has been proven in large randomized trials to reliably raise AMH, several approaches carry real and meaningful preliminary evidence — and the interventions themselves are safe, accessible, and often part of a broader fertility optimization protocol anyway.
Vitamin D correction. In a study of infertile women with both low vitamin D and low AMH, correcting vitamin D deficiency over three months was associated with a significant rise in AMH. Vitamin D deficiency is extraordinarily common and extraordinarily correctable. This is one of the most hopeful and most overlooked pieces of the fertility puzzle.
DHEA supplementation. At 25 mg three times daily over twelve weeks, DHEA showed significant increases in AMH and antral follicle count in women with diminished ovarian reserve, with the most pronounced benefit in women under 38. A Cochrane review suggests it may create a follicular environment that supports small antral follicle development. This is not a fringe approach — it is backed by real data.
Targeted micronutrient supplementation. A retrospective study of 244 women using a combination of omega-3 fatty acids, CoQ10, vitamin E, folic acid, selenium, and green tea catechins for three months found AMH increased meaningfully on average. The intervention is safe and the nutrients involved overlap significantly with standard evidence-based fertility protocols.
The honest clinical summary: we cannot promise that any intervention will raise your AMH. What we can do is identify and correct the deficiencies and imbalances that may be suppressing it, and build the best possible conditions for your remaining follicles to thrive.
That is a very different conversation than the one most women are sent home with.
What This Means at Materna
When we evaluate AMH at Materna, we do not hand you a number and send you on your way.
We look at your AMH alongside your antral follicle count on ultrasound, your FSH and estradiol drawn on the correct cycle day, your vitamin D level, your DHEAS, and your full metabolic and inflammatory picture. We ask whether you were on hormonal contraception when the number was drawn. We look at your cycle history, your symptoms, your lifestyle, and your goals.
And then we build a protocol around what we actually find — not around a single data point taken out of context.
Because here is what we know to be true after caring for women at every stage of this journey: age remains the strongest predictor of fertility treatment success. AMH guides the clinical approach. It does not determine the outcome.
If you have been given a low AMH number and told there is not much to be done, we would like to offer you a different conversation. One that starts with the full picture, takes your individual biology seriously, and meets you with the optimism that your situation actually warrants.
Most women who come to us carrying the weight of a low AMH result leave with something they did not expect.
Hope that is grounded in real information.
That is what we are here for.
Same-week appointments available at Materna Health in the West Village, New York City.
We're here for you - from the start
We’re redefining maternal health by replacing the ER with a welcoming, evidence-based care environment that centers you: your body, your symptoms, your experience.
Schedule a visit
Compassionate support for every stage of pregnancy
Contact
Connect with our dedicated support team
Phone
Direct line for immediate healthcare guidance
Office
Women's health center in
130 7th Ave S NY, NY 10014
130 7th Ave S NY, NY 10014
Related blogs and articles

Positive Signs of Pregnancy: How to Know for Sure
Wondering if you are pregnant? Learn the real difference between early pregnancy symptoms and the positive signs that confirm pregnancy for certain, from an NYC OB/GYN practice.

Beyond the 21 Day Progesterone: A Complete Hormonal Workup for Trying to Conceive
Most fertility workups stop at a few hormones drawn on day 21. Here is what a complete evaluation actually looks like, and why insulin, cortisol, and adrenal markers belong in the conversation.

Inside Materna Health's Grand Opening: Launching same day OB/GYN care
Materna Health celebrated its grand opening on April 23, 2026 in NYC's West Village. A look inside the night, the community, and the care we are building for early pregnancy and the forgotten in between.
